This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SAVR after TAVR Surgical aorticvalve replacement after prior TAVR is the fastest-growing cardiac surgery procedure in the U.S. The STS used recent national data from the STS Adult Cardiac Surgery Database between 2012 and 2023 to analyze outcomes of SAVR after previous TAVR.
BACKGROUND:Data concerning the outcomes of transcatheter aorticvalve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Self-expanding transcatheter heart valves were used in the majority of patients (n=1160; 91.4%). In the matched population, differences in mortality (30 days: 4.2%
The analysis included 4,798 patients from 207 STS sites who underwent esophagectomy between 2012-2019. Using the Society of Thoracic Surgeons Adult Cardiac Surgery Database , the study covers adult patients who underwent cardiac surgery after an initial TAVR from January 2012 to March 2023.
BackgroundAcute ischemic stroke complicates 2% to 3% of transcatheter aorticvalve replacements (TAVRs). This study aimed to identify the aortic anatomic correlates in patients after TAVR stroke.Methods and ResultsThis is a single‐center, retrospective study of patients who underwent TAVR at the Mayo Clinic between 2012 and 2022.
Background Treatment of severe aortic stenosis with transcatheter aorticvalve implantation (TAVI) was introduced in 2002. The 13-year period was divided into period 1 (2008–2012), period 2 (2013–2017), and period 3 (2018–2021).
Aortic stenosis is a narrowing of the aorticvalve which prevents the aortic leaflets from opening and closing properly. Two common approaches for treating aortic stenosis include surgical aorticvalve replacement (SAVR) and transcatheter aorticvalve replacement (TAVR).
Aortic stenosis is a narrowing of the aorticvalve which prevents the aortic leaflets from opening and closing properly. Two common approaches for treating aortic stenosis include surgical aorticvalve replacement (SAVR) and transcatheter aorticvalve replacement (TAVR).
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)
Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)
Background Transcatheter aorticvalve replacement (TAVR) is increasingly used for aorticvalve replacement instead of surgical aorticvalve replacement (sAVR). Methods Data were extracted from the Nationwide Readmissions Database from 2012 to 2017. Diabetes was present in 36.4% of sAVR patients.
ObjectivesThe bicuspid aorticvalve (BAV) is the most common congenital heart defect. years, who underwent a transthoracic echocardiographic examination and CMR at our institute from 2012 to 2020.ResultsThe years, who underwent a transthoracic echocardiographic examination and CMR at our institute from 2012 to 2020.ResultsThe
Background Bacteraemia and infective endocarditis (IE) are rare but severe complications of transcatheter aorticvalve implantation (TAVI). Limited data exist on the incidence and microbiological profile of early bacteraemia in this population.
BackgroundComparative long-term survival outcomes between transcatheter (TAVR) and surgical (SAVR) aorticvalve replacement remain debated. While randomized controlled trials support TAVR's non-inferiority, real-world data indicate the opposite. years, and median EuroSCORE II values of 1.9%, 4.0%, and 5.2%, respectively.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content